Medmain
Medmain's mission is to solve the global shortage of pathologists and the slow turnaround time associated with pathologic diagnoses.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD58m (Public information from Apr 2024)
Tokyo Japan (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | JPY10.0m | Early VC | |
$900k | Early VC | ||
| N/A | JPY200m | Seed | |
| N/A | JPY180m | Seed | |
| N/A | JPY500m | Series A | |
JPY1.1b | Early VC | ||
| N/A | JPY300m | Late VC | |
* | N/A | - | |
* | JPY850m Valuation: JPY5.5b | Series A | |
| Total Funding | CAD34.2m | ||
Related Content
Recent News about Medmain
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.